Background: The Apple Watch (AW) can record single-lead electrocardiograms (ECGs) and has been investigated for arrhythmia detection. In this study we evaluated its accuracy in identifying the origin of premature ventricular contractions (PVCs) vs. standard 12-lead ECGs.
Methods And Results: A total of 7 patients with PVCs were assessed using both 12-lead and AW ECG recordings. The QRS polarity observed in the AW recordings was consistent with that of the standard ECGs in most cases, demonstrating its utility in estimating three distinct PVC origins.
Conclusions: The AW holds potential as an auxiliary tool for PVC origin assessment, contributing to arrhythmia management in clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1253/circj.CJ-24-0815 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in Wearable Stethoscope Technology: Opportunities for the Early Detection and Prevention of Cardiovascular Diseases.
Cureus
December 2024
Physiology, American University of Antigua, St. John's, ATG.
Wearable technology, including devices like Apple and Samsung watches, Fitbits, and smart rings, has become widely popular. However, while these consumer electronics are readily available, they do not yet meet the accuracy and safety standards required for medical devices by the U.S.
View Article and Find Full Text PDFConnected health: Ventricular tachycardia detection with Apple Watch-A case report.
Heliyon
December 2024
Centro Cardiologico Monzino IRCCS, 20138, Milan, Italy.
Background: Traditional screening methods, such as 12-lead electrocardiograms (ECGs) and Holter monitors, often fall short in detecting transient arrhythmias. However, advancements in wearable technology, like the Apple Watch®, enable real-time rhythm monitoring and specific arrhythmia detection through dedicated algorithms.
Case Description: A 60-year-old man with a history of arrhythmogenic cardiomyopathy and an implanted cardioverter-defibrillator (ICD), during a walk, experienced palpitations and dizziness; the Apple Watch® alerted him of an elevated heart rate.
Usefulness of Apple Watch Electrocardiograms for Identifying the Origin of Premature Ventricular Contractions.
Circ J
December 2024
Department of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University.
Background: The Apple Watch (AW) can record single-lead electrocardiograms (ECGs) and has been investigated for arrhythmia detection. In this study we evaluated its accuracy in identifying the origin of premature ventricular contractions (PVCs) vs. standard 12-lead ECGs.
View Article and Find Full Text PDFCan heart rate sequences from wearable devices predict day-long mental states in higher education students: a signal processing and machine learning case study at a UK university.
Brain Inform
December 2024
School of Computing and Engineering, University of Huddersfield, Huddersfield, WYK, HD1 3DH, UK.
Article Synopsis
- Mental health concerns among university students are increasing, prompting research into how continuous heart rate monitoring via Apple Watch can indicate mental states, especially stress.
- The study is unique in its approach as it analyzes day-long heart rate fluctuations in real-world settings, contrasting previous research that focused on isolated tests in controlled environments.
- Using advanced signal processing and machine learning techniques, the research has shown statistically significant results, suggesting heart rate data can effectively characterize mental states, paving the way for future testing and data collection.
Development of a remote therapeutic monitoring platform: applications for movement disorders.
Sci Rep
December 2024
Abbott Neuromodulation, Plano, TX, USA.
Digital health tools are emerging as a promising solution for optimizing Deep Brain Stimulation (DBS) therapy for neurodegenerative diseases such as Parkinson's Disease (PD), addressing challenges of therapy maintenance, care access, and discrete assessments. Wearable technology and mobile health platforms can offer remote monitoring capabilities, allowing for real-time virtual programming with optimization of patients' therapy, use of digital biomarkers that can help identify the onset, symptoms, medication-related fluctuations and side-effects, and response to DBS treatment. Through an investigational remote monitoring application (RM app) integrating patient-reported outcomes (PROs) and objective data using wearables, we aimed to develop an accessible, data-driven digital tool to monitor patient symptoms and deliver low-burden and easy-to-access DBS therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!